590: A lipid nanoparticle–based delivery system for the treatment of CF
James V. Sullivan, Richard Wooster(GlaxoSmithKline (United States)), Chang‐Hoon Woo(Daegu Haany University), A. Paksa, Balkrishen Bhat, Neeraj Kaushal, Shrirang Karve, Guodong Sun(Zhejiang Entry-Exit Inspection and Quarantine Bureau), Frank DeRosa(Sanofi (United States)), J. Androsavich
Cited by 0
Related Papers
Subtype and pathway specific responses to anticancer compounds in breast cancer
|Proceedings of the National Academy of Sciences|2011|505
hucMSC derived exosomes promote functional recovery in spinal cord injury mice via attenuating inflammation
|Materials Science and Engineering C|2018|351
Synthesis and Biological Evaluation of Ionizable Lipid Materials for the In Vivo Delivery of Messenger RNA to B Lymphocytes
|Advanced Materials|2017|280
Bioinspired Alkenyl Amino Alcohol Ionizable Lipid Materials for Highly Potent In Vivo mRNA Delivery
|Advanced Materials|2016|243
ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
|Journal of Experimental & Clinical Cancer Research|2021|206